Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 64
Number Thumbnail Title Author Date Votes Views
44 Busan Mayor Visits Prestige Biopharma IDC to Support Regional Bioindustry Growth
김** | 2025.11.05 | Votes 0 | Views 313
김** 2025.11.05 0 313
43 Prestige Biopharma Presents PAUF-Based Pancreatic Cancer Program at ESMO 2025
we******** | 2025.10.21 | Votes 0 | Views 336
we******** 2025.10.21 0 336
42 Prestige Biopharma IDC Files Patent for Sustained-Release Subcutaneous Delivery Platform for High-Concentration Protein Therape
김** | 2025.10.14 | Votes 0 | Views 363
김** 2025.10.14 0 363
41 Prestige Biopharma IDC Publishes IHC-Based PAUF Diagnostic Platform Study in International Journal
we******** | 2025.09.17 | Votes 0 | Views 200
we******** 2025.09.17 0 200
40 Prestige Biopharma IDC Signs Joint Development Agreement with Geovista for Companion Animal Therapeutics
김** | 2025.09.16 | Votes 0 | Views 262
김** 2025.09.16 0 262
39 Prestige Biopharma IDC Selected as a Core Research center in Korea’s ARPA-H Project
김** | 2025.08.20 | Votes 0 | Views 258
김** 2025.08.20 0 258
38 PPrestige Biopharma Secures European Patent for Pancreatic Cancer Antibody PBP1510
김** | 2025.08.01 | Votes 0 | Views 267
김** 2025.08.01 0 267
37 Prestige Biopharma IDC Files Patent for Anti-CTHRC1 Antibody Combination Therapy for Solid Tumors
we******** | 2025.07.28 | Votes 0 | Views 162
we******** 2025.07.28 0 162
36 Prestige Biopharma IDC Hosts Regional R&D Engagement Tour with BISTEP and Civic Groups
we******** | 2025.07.16 | Votes 0 | Views 215
we******** 2025.07.16 0 215
35 Prestige Biopharma IDC Shares Antibody-Based Drug Research with KAIST Professors
김** | 2025.07.10 | Votes 0 | Views 257
김** 2025.07.10 0 257

Read Prestige news >>